
Medrobotics Stock
Medrobotics Corporation is a medical robotics company developing and commercializing the Flex Robotic System.
Sign up today and learn more about Medrobotics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Medrobotics Stock
Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical "snake robotics" platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company. Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.
Funding History
February 2011 | $6.5M |
---|---|
May 2011 | $3.6M |
November 2011 | $11.7M |
August 2012 | $8.0M |
December 2012 | $33.6M |
March 2013 | $10.0M |
May 2014 | $26.0M |
October 2014 | $20.0M |
November 2015 | $25.0M |
January 2017 | $20.0M |
Management
Vice President, Global Sales
Richard Walsh
Chief Financial Officer & Treasurer
Mark Peters
Vice President, Clinical, Regulatory & Quality Affairs
John Bonasera
Vice President, Intellectual Property Strategy
Christopher Flaherty
Co-Founder
Howie Choset
Chairman of the Board of Directors
James Jordan
Vice President of Operations
Michael Gallagher
Founder
Alon Wolf
Vice President, Marketing
Thomas Patzelt
President & CEO
Samuel Straface
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase